Surjit Moolamalla, MD
Obstetrics & Gynecology · Las Cruces, NMNPI 1306849310
Payments from drug & device makers
What this record shows
27 manufacturers reported payments, led by Gynesonics, Inc. at 46.8% of the total. Reporting peaked in 2020 at $2,080 and has fallen 89.3% since, to $223 in 2025. Among obstetrics & gynecology clinicians in NM with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 70 payments — averaging $51.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gynesonics, Inc.$2K
- Coloplast$727
- AbbVie$175
- Intuitive Surgical$132
- Sage Therapeutics, LLC$104
- Aspira Women's Health Inc$101
- plus $672 from 21 others
What the payments were for
- Travel & lodging$1,58044%
- Food & beverage$2,01356%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gynesonics, Inc. | 6 | $1,682 |
| Coloplast | 5 | $727 |
| AbbVie | 10 | $175 |
| Intuitive Surgical | 5 | $132 |
| Sage Therapeutics, LLC | 5 | $104 |
| Aspira Women's Health Inc | 4 | $101 |
| Medical Device Business Services, Inc. | 1 | $70 |
| Bayer | 4 | $67 |
| Coopersurgical, Inc. | 5 | $59 |
| Boston Scientific | 1 | $50 |
| Pfizer | 3 | $47 |
| Astellas Pharma US Inc | 2 | $46 |
| Exeltis, USA Inc. | 2 | $36 |
| Minerva Surgical, Inc | 2 | $29 |
| Organon | 2 | $29 |
| Smith+Nephew | 2 | $27 |
| Davol Inc. | 1 | $25 |
| Hologic Sales And Service, LLC | 1 | $25 |
| Vertex | 1 | $23 |
| Olympus America Inc. | 1 | $23 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| Sanofi Pasteur Inc. | 1 | $20 |
| Myovant Sciences Inc. | 1 | $18 |
| Johnson & Johnson | 1 | $16 |
| Therapeuticsmd, Inc. | 1 | $14 |
| Merck | 1 | $14 |
| Agile Therapeutics, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,593 in reported general payments places this provider in the 90th percentile of 181 obstetrics & gynecology providers in New Mexico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 25 | $14,193 |
| Estradiol | 128 | $6,779 |
| Norethindrone Acetate | 13 | $517 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 18 | $484 |
| Oxybutynin Chloride ErOxybutynin Chloride | 21 | $210 |
| ProgesteroneProgesterone, Micronized | 14 | $194 |
| Medroxyprogesterone Acetate | 11 | $167 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 25 | $136 |
| Ibuprofen | 25 | $120 |
| Gabapentin | 12 | $113 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $46 | $14,19325 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 181 obstetrics & gynecology providers in New Mexico.
Other obstetrics & gynecology in Las Cruces
- Dara SomLas Cruces$6K
- Shirley HinshawLas Cruces$5K
- Marisa GriegoLas Cruces$3K
- Paula DelgadoLas Cruces$2K
- Joseph OrtizLas Cruces$2K
- Shahrzad TabibiLas Cruces$1K
- Elma GutierrezLas Cruces$1K
- Kristen CastilloLas Cruces$1K
- Kristen GorbitzLas Cruces$1K
- Alyson OteroLas Cruces$449
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.